A study on the correlation between smoking, light to moderate alcohol consumption, and cognitive function in elderly men in the community
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 4
Abstract
[Objective] To explore the correlation between smoking, light to moderate alcohol consumption and cognitive function in elderly men in the community. [Methods] One thousand two hundred one elderly men (excluding heavy drinkers) from the Chinese longitudinal aging cohort database were selected and divided into smoking and drinking group (n=332), non-smoking but drinking group (n=126), smoking but non-drinking group (n=308), and non-smoking and non-drinking group (n=435) based on self-provided smoking and drinking information. Cognitive function was evaluated using the Beijing version of the Montreal cognitive assessment (MoCA). A two factor ANOVA and a multiple factor linear regression model were used to analyze differences in cognitive function, and risk factors for cognitive decline, respectively. [Results] The main effect analysis indicated that light to moderate alcohol consumption had a statistically significant impact on MoCA total score (F=6.076, P=0.014), MoCA naming (F=1.179, P=0.001), and MoCA abstraction (F=7.718, P=0.006). Light to moderate drinkers had lower MoCA total score (22.50±5.27 vs. 23.30±5.28), MoCA naming (2.41±0.85 vs.2.58±0.76), and MoCA abstraction (0.93±0.84 vs. 1.10±0.82) compared to non-drinkers. The main effects of smoking on MoCA total score (F=0.234, P=0.628), MoCA naming (F=0.110, P=0.741), and MoCA abstraction (F=1.335, P=0.248) were not significant. There was no interaction between smoking and light to moderate alcohol consumption on MoCA score (P>0.05). The results of multiple factor linear regression analysis showed a positive correlation (B=0.125, P=0.008) between no history of light to moderate alcohol consumption and MoCA naming. A stratified analysis of non-dementia individuals showed a positive correlation between a history of light to moderate alcohol consumption and MoCA total score (B=0.550, P=0.011) and MoCA naming (B=0.134, P=0.002). [Conclusion] Smoking and light to moderate alcohol consumption have no significant mutual effect on cognitive function in elderly men in the community, while light to moderate alcohol consumption may be associated with the impairments in global cognitive and naming functions.
Authors and Affiliations
Bin LI, Yongchao LI, Yan SONG, Xia LI, Shifu XIAO, Lin. SUN
Keywords
Related Articles
- EP ID EP750482
- DOI 10.3969/j.issn.1002-0152.2024.04.004
- Views 28
- Downloads 0
The rh-CSF1 improves mitochondrial function and cell apoptosis in neurons under oxygen-glucose deprivation
[Objective] To investigate the mechanism by which Colony Stimulating Factor-1 (CSF1) inhibits apoptosis in neurons subjected to oxygen-glucose deprivation (OGD). [Methods] Primary rat cortical neurons were divided into t...
Application of speech repetition task in the detection of mild cognitive impairment
Mild cognitive impairment (MCI) is often regarded as a prodromal stage of dementia, primarily characterized by mild decline in cognitive function. Due to the mild nature of its symptoms, many MCI cases miss the opportuni...
Stereotactic electroencephalography-guided electrical stimulation-induced smile and laughter: a report of two cases
The network of laughter/smile production and propagation in the brain is not yet fully understood. In this paper, we report two cases of medically refractory epilepsy patients with stereotactic EEG implantation, in which...
Research progress of sensory and perceptual abnormalities in children with autism spectrum disorder
Sensory and perceptual abnormalities are one of the symptoms of children with autism spectrum disorder (ASD), which have a profound impact on children's social interaction, learning and overall function. The clinical fea...
a case of paraneoplastic cerebellar ataxia syndrome associated with immunocheckpoint inhibitor treated with Ofatumumab
A case of paraneoplastic cerebellar ataxia syndrome caused by immune checkpoint inhibitors (ICI) was treated with ofatumumab (OFA). The patient is a 57-year-old male. He used “Camrelizumab” immunotherapy for his previous...